First Quadrant’s Medicines Co MDCO Stock Holding History

First Quadrant’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,583	Closed	-$60K	–	1010
2017 Q2	$60K	Hold	1,583	–	–	﹤0.01%	814
2017 Q1	$77K	Hold	1,583	–	–	﹤0.01%	717
2016 Q4	$54K	Hold	1,583	–	–	﹤0.01%	769
2016 Q3	$60K	Sell	1,583 -617	-28%	-$23.3K	﹤0.01%	767
2016 Q2	$74K	Hold	2,200	–	–	﹤0.01%	673
2016 Q1	$70K	Sell	2,200 -27,800	-93%	-$908K	﹤0.01%	667
2015 Q4	$1.12M	Sell	30,000 -1,400	-4%	-$52.9K	0.02%	372
2015 Q3	$1.19M	Hold	31,400	–	–	0.03%	350
2015 Q2	$898K	Hold	31,400	–	–	0.02%	386
2015 Q1	$880K	Hold	31,400	–	–	0.02%	374
2014 Q4	$869K	Hold	31,400	–	–	0.02%	374
2014 Q3	$701K	Hold	31,400	–	–	0.02%	408
2014 Q2	$912K	Sell	31,400 -1,200	-4%	-$32K	0.02%	399
2014 Q1	$926K	Sell	32,600 -4,200	-11%	-$139K	0.02%	382
2013 Q4	$1.42M	Sell	36,800 -3,200	-8%	-$114K	0.03%	346
2013 Q3	$1.34M	Hold	40,000	–	–	0.03%	335
2013 Q2	$1.23M	Buy	+40,000	New	+$1.34M	0.03%	338

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Quadrant's MDCO Position: Q3 2017 in Review

First Quadrant sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 1,583 shares — an estimated $60K sold.

First Quadrant first reported a position in MDCO in Q2 2013 and held it in 17 quarters. The position peaked at $1.42M in Q4 2013. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

First Quadrant reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
First Quadrant sold 1,583 Medicines Co shares in Q3 2017, an estimated $60K.
First Quadrant first reported a position in Medicines Co in Q2 2013 and held it in 17 quarters.
First Quadrant's Medicines Co position peaked at $1.42M in Q4 2013.
190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on First Quadrant's 13F filing for Q3 2017, filed 25 Oct 2017.